A $44.5 million settlement has been reached in the class action lawsuit filed on behalf of consumers who purchased the blood-thinning medication, Coumadin. The suit alleged that the company disseminated false and misleading information about generic versions of Coumadin. (Dec-10-04)
[THE DAILY ITEM]
If you have a similar problem and would like to be contacted by a lawyer at no obligation, please click here to fill in our form
to submit your complaint.